Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Presence of 4‑Hydroxy‑<i>N</i>‑methyl‑<i>N</i>‑ethyltryptamine in Commercially Available Products.

Barovic A, Pittiglio MK, Barrett JM, Aretz CDJ, Tesfatsion TT, Ramirez GA, Cruces WiD

ACS omegaJan 7, 2026License: open accessUnited States0 citationsDOI: 10.1021/acsomega.5c10889

Abstract

Novel psychoactive substances (NPS) remain an ongoing challenge for public health, forensic laboratories, and regulatory agencies, especially when they are chemically related to controlled tryptamines but are marketed as legal alternatives. In the United States, the Federal Analogue Act (FAA) was intended to restrict such substances; however, regulatory loopholes continue to be exploited. Herein, we present the characterization of a commercially available tablet marketed under the brand name Party Duck, alongside an unlabeled powder provided by our laboratory. Samples were analyzed using nuclear magnetic resonance (NMR) spectroscopy, gas chromatography/mass spectrometry (GC/MS), and liquid chromatography/mass spectrometry (LC/MS). All materials were identified to contain 4-hydroxy-<i>N</i>-methyl-<i>N</i>-ethyltryptamine (4-HO-MET), a synthetic psychedelic structure and pharmacologically similar to psilocin. The mean concentration of 4-HO-MET in the tablets was determined to be 2.82 or 1.45 mg/tablet, while the powder was confirmed qualitatively to contain the same compound. These findings demonstrate that 4-HO-MET is present in commercially available products and emphasize the importance of rigorous analytical methods for continuous monitoring of tryptamine derivatives in unregulated markets.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.